PT (prothrombin time) and PTT (partial thromboplastin time) are blood tests that measure how long it takes your blood to form a clot. A normal PT is about 10 to 13 seconds, and a normal PTT is 25 to 35 seconds. Doctors order these tests to check for bleeding disorders, monitor blood-thinning medications, or evaluate clotting problems before surgery.
Both tests involve drawing blood into a light-blue tube containing a substance that temporarily prevents clotting. In the lab, chemicals are added to trigger clotting, and a timer measures how many seconds it takes for a clot to form. The key difference is that each test activates a different part of your clotting system, so they catch different problems.
How PT and PTT Test Different Clotting Pathways
Your body forms clots through a chain reaction involving more than a dozen clotting factors, which are proteins made mostly by the liver. These factors work in sequence, like dominoes falling in a line. There are two main entry points into this chain reaction, called the extrinsic and intrinsic pathways, and they merge into a shared final stretch called the common pathway.
PT measures the extrinsic pathway. This pathway is the faster route to clotting and involves a smaller set of clotting factors, including factors I (fibrinogen), II (prothrombin), VII, and X. It kicks in when blood vessels are damaged and tissue factor is released.
PTT measures the intrinsic pathway, which involves a larger group of factors: I, II, IX, X, XI, and XII. This pathway responds to damage inside blood vessels and takes longer to activate, which is why normal PTT values are higher than PT values.
Because both pathways share the common pathway (factors I, II, V, VIII, and X), a problem with one of those shared factors can make both PT and PTT abnormal at the same time. When only one test is prolonged, it points toward a problem specific to that pathway, which helps narrow down the cause.
What a Prolonged PT Means
A PT result longer than 13 seconds suggests a problem with the extrinsic or common clotting pathway. Several conditions can cause this:
- Liver disease: The liver produces most clotting factors. When liver function declines, factor production drops and PT rises. This is one of the most common reasons for an elevated PT.
- Vitamin K deficiency: Your body needs vitamin K to make factors II, VII, IX, and X. Poor nutrition, prolonged antibiotic use, and problems absorbing fat (since vitamin K is fat-soluble) can all deplete vitamin K levels.
- Blood-thinning medication: Warfarin works by blocking vitamin K, which intentionally prolongs PT. The test is used to make sure the dose keeps clotting in the right range.
- Inherited factor deficiencies: Rare genetic conditions that reduce production of specific clotting factors can prolong PT from birth.
- Disseminated intravascular coagulation (DIC): This serious condition triggers widespread clotting throughout the body, which uses up clotting factors faster than they can be replaced, eventually prolonging both PT and PTT.
What a Prolonged PTT Means
A PTT longer than 35 seconds points toward issues in the intrinsic pathway. The most well-known causes are hemophilia A and hemophilia B, inherited conditions where the body doesn’t produce enough of specific clotting factors (factor VIII and factor IX, respectively). People with hemophilia typically have a prolonged PTT but a normal PT, because the extrinsic pathway isn’t affected.
Von Willebrand disease, the most common inherited bleeding disorder, can also prolong PTT in its more severe forms. In type 3 and type 2N von Willebrand disease, factor VIII levels drop low enough to push PTT above normal. However, in milder forms of von Willebrand disease, PTT is often completely normal, so a normal result doesn’t rule it out.
Factor XI deficiency is another cause that PTT is particularly good at catching. Heparin, an injectable blood thinner used in hospitals, also prolongs PTT, and doctors use PTT to monitor its effects.
INR: A Standardized Version of PT
PT results can vary between laboratories because different labs use slightly different reagents. To solve this, PT is often converted into a standardized number called the INR (international normalized ratio). An INR of 1.0 is normal clotting. Higher numbers mean slower clotting.
If you take warfarin, your target INR is typically 2.0 to 3.0. This range applies to most conditions that require blood thinning, including atrial fibrillation, blood clots in the legs or lungs, and tissue heart valves. People with mechanical heart valves at high risk of clots may need a slightly higher range of 2.5 to 3.5. Regular blood draws, sometimes weekly, keep your INR within that window.
How Heparin Monitoring Uses PTT
While warfarin is tracked with PT and INR, heparin is tracked with PTT. When you receive heparin through an IV in a hospital, the goal is to raise your PTT to 1.5 to 2.5 times the upper limit of normal. In practical terms, that often means a target of roughly 65 to 109 seconds, though the exact range varies by lab. Nurses draw blood every few hours to check PTT and adjust the heparin dose up or down accordingly.
When Both Tests Are Ordered Together
Ordering PT and PTT together gives a more complete picture of your clotting system. If PT is prolonged but PTT is normal, the problem likely involves factor VII, which is unique to the extrinsic pathway. If PTT is prolonged but PT is normal, the issue is in the intrinsic pathway, pointing toward conditions like hemophilia. If both are prolonged, the problem is either in the shared common pathway, or it’s something systemic like liver disease, vitamin K deficiency, or DIC that affects multiple factors at once.
Before surgery, both tests are sometimes checked to make sure you don’t have an undiagnosed bleeding disorder that could cause complications. They’re also ordered when someone has unexplained bruising, bleeding that won’t stop, or a family history of clotting problems. The combination of results, along with your symptoms and medical history, guides doctors toward the right diagnosis.